Ascletis BioScience Co., Ltd. (Hangzhou) Reviews, Salaries and Jobs

Company Overview

Nature: Listed Company Size: 100-499 employees Founded: 13年
Industry: Pharmaceuticals/Biotechnology 、 Raw Materials and Processing
Full name: Ascletis BioScience Co., Ltd. (Hangzhou)。

Development Stage

Stage: B轮, 1亿美元。
Ranking: Ranked #752 in Hangzhou City by popularity Ranked #4 in 杭州化学原料药公司 by popularity Ranked #5 in 杭州化学制药公司 by popularity Ranked #6 in 杭州化工原料公司 by popularity Ranked #6 in 杭州仿制药公司 by popularity
Honors: 高新技术企业省级专精特新中小企业 According to algorithm
News: 2026-02-11：歌礼制药：选定口服胰淀素受体激动剂多肽ASC36进行临床开发。
Salary: 66.7% of positions earn 10-30K, In 2026 vs last yeargrew by 11%.。Master's salary: ¥26.8K.
R&D: "其他（研发和技术类）" demand: 24.1%, "生物/制药/化工/环保类": 22.2%, "科研类": 14.8%。
Recruiting: In 2026 vs 2025grew by 72%. Demand for highly educated talent: Master's: 9.
Requirement: Education: 本科 leads with 62.1%. Experience: 3-5年 leads with 36.4%.
Region: Distributed across 2 regions, 杭州: 72.7%, 绍兴: 25.8%, 苏州: 1.5%.

About the Company

[Summary] Committed to addressing unmet medical needs in three major disease are

Ascletis is a fully integrated value-chain biotechnology company focused on the development and commercialization of drugs expected to be best-in-class and first-in-class for metabolic diseases. Leveraging its proprietary AI-assisted structure-based drug discovery (AISBDD), Ultra-Long-Acting Platform (ULAP) technology, and oral peptide transport enhancement technology (POTENT), Ascletis has independently developed multiple small molecule and peptide drug candidates, including its core project ASC30, an investigational small molecule GLP-1R agonist that can be administered orally once daily or subcutaneously once monthly to once quarterly as a weight loss treatment and weight loss maintenance therapy for long-term weight management; ASC36, an amylin receptor agonist peptide; ASC35, a once-monthly subcutaneous GLP-1R/GIPR dual-target agonist peptide; ASC37, a GLP-1R/GIPR/GCGR triple-target agonist peptide; ASC39, a potent oral small molecule amylin receptor agonist similar to eloralintide with selectivity for amylin; and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1RA) and ASC39 (amylin receptor agonist) for long-term weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK). For more information, please visit the website: *.

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

Ascletis News (13 items)

Manage

歌礼制药：选定口服胰淀素受体激动剂多肽ASC36进行临床开发

From 36氪 2026-02-11 08:10:03

歌礼制药：选定激动剂多肽ASC35进入临床开发阶段

From 36氪 2025-10-13 08:37:02

歌礼制药：ASC30在美国Ib期研究中展现出良好且具差异化的药代动力学特征

From 36氪 2025-08-28 08:55:03

歌礼制药：拟折让约9.9%配售5240万股，净筹约467.69百万港元

From 36氪 2025-08-19 07:43:02

Ascletis Financing History (2 rounds)

Manage

B轮

Capital Market Favor

Latest Financing Round

Date: ?
Amount: 1亿美元
Investor: 康桥资本，分众传媒，高盛集...

Ascletis How Fast Is Hiring Growing? (32 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Up 53%
2024: Down 64%
2023: Down 20%
2022: Up 8%

Ascletis Year-by-Year Hiring:

2021 61 jobs 2022 66 jobs 2023 53 jobs 2024 19 jobs 2025 29 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

Hangzhou 17 Shaoxing 5 Suzhou 1

Ascletis Campus Recruitment & Advanced Degree Talent Demand

Master's 9

No.443

Recruitment Growth Ranking in Hangzhou City 򀀩

Ascletis Latest Jobs

Note: How fast is hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? Ascletis2025: 29 openings (up 53%), 2024: 19 openings (down 64%), 2023: 53 openings (down 20%), 2022: 66 openings (up 8%), 2021: 61 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Ascletis Master's Degree Job Demand Analysis

(More)

Growth Rate

2026 vs 2025

2025: Down 75%
2024: Down 43%
2023: Down 13%
2022: Up 60%

Ascletis Master's Hiring by Year:

2021 5 jobs 2022 8 jobs 2023 7 jobs 2024 4 jobs 2025 1 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? AscletisMaster's recruitment over the years: 2025: 1 openings (down 75%), 2024: 4 openings (down 43%), 2023: 7 openings (down 13%), 2022: 8 openings (up 60%), 2021: 5 openings.

Ascletis Doctoral Degree Job Demand Analysis

(More)

N/A

Growth Rate

Ascletis Doctoral Hiring by Year: 2024 — 4 fewer jobs than 2023

2021 1 jobs 2022 5 jobs 2023 5 jobs 2024 1 jobs

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Doctoral Salary 򀀩

How fast is doctoral hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? AscletisDoctorate recruitment over the years: 2024: 1 openings (down 43%), 2023: 5 openings (down 13%), 2022: 5 openings (up 60%), 2021: 1 openings.

Ascletis R&D Strength (Technical Talent Demand)

(More)

其他（研发和技术类）: 13 roles, 24.1% of total. Hot jobs:

How is the demand for technical talent at Ascletis BioScience Co., Ltd. (Hangzhou)? Based on an analysis of Ascletis's job postings over the past year, "其他（研发和技术类）" demand: 24.1%, "生物/制药/化工/环保类": 22.2%, "科研类": 14.8%, "医疗卫生/美容保健类": 13%, "计算机/网络/技术类": 7.4%, "机械/仪器仪表类": 3.7%. For reference only.

Ascletis — What Are the Salaries Like? (54 records)

Manage

Ascletis Salary Overview

￥10-30K

66.7% of roles pay

salary range: 2K - 50K, 66.7% of roles pay ￥10-30K

1.9% 2-3K 9.3% 6-8K 9.3% 8-10K ***  ? 10-15K 13% 15-20K ***  ? 20-30K 13% 30-50K

Note: salary statistics are based on 54 salary records from the past year and depend on the job sample. For reference only.

Ascletis Salary Ranking

By Category

经营管理类￥19.7K  其他（研发和技术类）  生物/制药/化工/环保类  质量管理类  科研类 

How is the salary at Ascletis BioScience Co., Ltd. (Hangzhou)?Ascletis66.7% of positions earn 10-30K, Undergraduate salary: ¥。经营管理类 average salary ¥19.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Ascletis

(More)

Are salaries high at Ascletis BioScience Co., Ltd. (Hangzhou)? We provide: 研究员，总裁，qc，分析，临床，招聘主管，运营，高级专员，高级主管，dm，出纳，有机合成，注册经理，行政，质量，采购，cmc总监，ehs，it经理，qa. Click to view detailed salary analysis by job.

Ascletis honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Ascletis Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

经营管理类
36.4% of total 36.4%
其他（研发和技术类）
22.7% of total 22.7%
生物/制药/化工/环保类
22.7% of total 22.7%
质量管理类
16.7% of total 16.7%

Job Location

Education

本科
62.1% of total 62.1%
硕士
25.8% of total 25.8%
大专
10.6% of total 10.6%
不限
1.5% of total 1.5%

Experience

3-5年
36.4% of total 36.4%
5-10年
30.3% of total 30.3%
1-3年
24.2% of total 24.2%
不限
9.1% of total 9.1%

View Detailed Analysis

What does Ascletis BioScience Co., Ltd. (Hangzhou) require? Who is Ascletis hiring? Ascletis recruitment: 经营管理类占比最多占36.4%，其次是其他（研发和技术类）占22.7%. What education can get in at Ascletis? 本科占比最多占62.1%，其次是硕士占25.8%. High education required at Ascletis? 硕士占25.8%. Work experience required at Ascletis? 3-5年占比最多占36.4%，其次是5-10年占30.3%. Where are the job locations at Ascletis? 杭州占比最多占72.7%，其次是绍兴占25.8%. Based on job postings from the past year, for reference only.